{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:43:54Z","timestamp":1780364634310,"version":"3.54.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"publisher","award":["CA184\/2711"],"award-info":[{"award-number":["CA184\/2711"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"publisher","award":["CA184\/2711"],"award-info":[{"award-number":["CA184\/2711"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1966\/18"],"award-info":[{"award-number":["1966\/18"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011600","name":"Cancer Biology Research Center, Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02823-1","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:08:27Z","timestamp":1774325307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Induction of caspase-mediated suppression of interferon signaling potentiates viral oncolysis of resistant tumor cells"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0436-5531","authenticated-orcid":false,"given":"Vladimir","family":"Bozhdansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Tayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Kashkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-2833","authenticated-orcid":false,"given":"Eran","family":"Bacharach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2352-1808","authenticated-orcid":false,"given":"Marcelo","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2823_CR1","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","volume":"86","author":"AM Tsimberidou","year":"2020","unstructured":"Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2823_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff M-A, Pereira RS, Pieper NM, et al. The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Therapy. 2025;10(1):91.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1\u20132","key":"2823_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1\u20132):20\u201338.","journal-title":"Apoptosis"},{"key":"2823_CR4","doi-asserted-by":"crossref","unstructured":"Ehrlich M, Bacharach E. Oncolytic Virotherapy: The Cancer Cell Side. Cancers (Basel). 2021;13(5):939.","DOI":"10.3390\/cancers13050939"},{"issue":"1","key":"2823_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.13272","volume":"321","author":"P Holicek","year":"2024","unstructured":"Holicek P, Guilbaud E, Klapp V, Truxova I, Spisek R, Galluzzi L, et al. Type I interferon and cancer. Immunol Rev. 2024;321(1):115\u201327.","journal-title":"Immunol Rev"},{"issue":"11","key":"2823_CR6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","volume":"6","author":"GP Dunn","year":"2006","unstructured":"Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006;6(11):836\u201348.","journal-title":"Nat Rev Immunol"},{"key":"2823_CR7","doi-asserted-by":"crossref","unstructured":"von Locquenghien M, Rozal\u00e9n C, Celi\u00e0-Terrassa T. Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response. J Clin Investig. 2021;131(1):e143296.","DOI":"10.1172\/JCI143296"},{"issue":"2","key":"2823_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","volume":"98","author":"YCS Ram\u00f3n","year":"2020","unstructured":"Ram\u00f3n YCS, Ses\u00e9 M, Capdevila C, Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl). 2020;98(2):161\u201377.","journal-title":"J Mol Med (Berl)"},{"issue":"23","key":"2823_CR9","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"R Bayat Mokhtari","year":"2017","unstructured":"Bayat Mokhtari R, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, et al. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022\u201343.","journal-title":"Oncotarget"},{"key":"2823_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in Cell Death, Inflammation, and Pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2823_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495\u2013516.","journal-title":"Toxicol Pathol"},{"issue":"22","key":"2823_CR12","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","volume":"14","author":"FC Kischkel","year":"1995","unstructured":"Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, et al. Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo j. 1995;14(22):5579\u201388.","journal-title":"Embo j"},{"issue":"9","key":"2823_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11(9):621\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2823_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","volume":"5","author":"AN Hata","year":"2015","unstructured":"Hata AN, Engelman JA, Faber AC. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics. Cancer Discov. 2015;5(5):475\u201387.","journal-title":"Cancer Discov"},{"issue":"1","key":"2823_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ccell.2016.11.011","volume":"31","author":"KA Sarosiek","year":"2017","unstructured":"Sarosiek KA, Fraser C, Muthalagu N, Bhola PD, Chang W, McBrayer SK, et al. Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics. Cancer Cell. 2017;31(1):142\u201356.","journal-title":"Cancer Cell"},{"issue":"7042","key":"2823_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"T Oltersdorf","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435(7042):677\u201381.","journal-title":"Nature"},{"issue":"2","key":"2823_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19(2):202\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"2823_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","volume":"10","author":"M Konopleva","year":"2006","unstructured":"Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006;10(5):375\u201388.","journal-title":"Cancer Cell"},{"issue":"9","key":"2823_CR19","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1182\/blood-2008-05-156851","volume":"113","author":"KF Whitecross","year":"2009","unstructured":"Whitecross KF, Alsop AE, Cluse LA, Wiegmans A, Banks K-M, Coomans C, et al. Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors. Blood. 2009;113(9):1982\u201391.","journal-title":"Blood"},{"issue":"5","key":"2823_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc2615","volume":"9","author":"MS Cragg","year":"2009","unstructured":"Cragg MS, Harris C, Strasser A, Scott CL. Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer. 2009;9(5):321\u20136.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2823_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","volume":"29","author":"L Gandhi","year":"2011","unstructured":"Gandhi L, Camidge DR, Ribeiro de Oliveira M, Bonomi P, Gandara D, Khaira D, et al. Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J Clin oncology: official J Am Soc Clin Oncol. 2011;29(7):909\u201316.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"12","key":"2823_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","volume":"11","author":"WH Wilson","year":"2010","unstructured":"Wilson WH, O\u2019Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11(12):1149\u201359.","journal-title":"Lancet Oncol"},{"key":"2823_CR23","doi-asserted-by":"crossref","unstructured":"Khan S, Cao L, Wiegand J, Zhang P, Zajac-Kaye M, Kaye FJ et al. PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer. Cells. 2024;13(6):528.","DOI":"10.3390\/cells13060528"},{"issue":"2","key":"2823_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87\u2013103.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2823_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/imr.12001","volume":"250","author":"J Piehler","year":"2012","unstructured":"Piehler J, Thomas C, Garcia KC, Schreiber G. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev. 2012;250(1):317\u201334.","journal-title":"Immunol Rev"},{"issue":"1","key":"2823_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Therapy. 2021;6(1):402.","journal-title":"Signal Transduct Target Therapy"},{"issue":"4","key":"2823_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024;57(4):752\u201371.","journal-title":"Immunity"},{"issue":"2","key":"2823_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ccell.2025.01.009","volume":"43","author":"J Schiantarelli","year":"2025","unstructured":"Schiantarelli J, Benamar M, Park J, Sax HE, Oliveira G, Bosma-Moody A, et al. Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma. Cancer Cell. 2025;43(2):308\u2013. \u2013\u200916.e6.","journal-title":"Cancer Cell"},{"issue":"9","key":"2823_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S, et al. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. N Engl J Med. 2016;375(9):819\u201329.","journal-title":"N Engl J Med"},{"issue":"32","key":"2823_CR30","doi-asserted-by":"publisher","first-page":"52115","DOI":"10.18632\/oncotarget.10313","volume":"7","author":"O Danziger","year":"2016","unstructured":"Danziger O, Shai B, Sabo Y, Bacharach E, Ehrlich M. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection. Oncotarget. 2016;7(32):52115\u201334.","journal-title":"Oncotarget"},{"key":"2823_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fimmu.2018.00094","volume":"9","author":"O Danziger","year":"2018","unstructured":"Danziger O, Pupko T, Bacharach E, Ehrlich M. Interleukin-6 and Interferon-alpha Signaling via JAK1-STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States. Front Immunol. 2018;9:94.","journal-title":"Front Immunol"},{"issue":"9","key":"2823_CR32","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/ijc.33401","volume":"148","author":"S Dellac","year":"2021","unstructured":"Dellac S, Ben-Dov H, Raanan A, Saleem H, Zamostiano R, Semyatich R, et al. Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus. Int J Cancer. 2021;148(9):2321\u201334.","journal-title":"Int J Cancer"},{"issue":"7","key":"2823_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/77558","volume":"6","author":"DF Stojdl","year":"2000","unstructured":"Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med. 2000;6(7):821\u20135.","journal-title":"Nat Med"},{"issue":"3","key":"2823_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol. 2023;20(3):160\u201377.","journal-title":"Nat Rev Clin Oncol"},{"issue":"23","key":"2823_CR35","doi-asserted-by":"publisher","first-page":"e2206948","DOI":"10.1002\/smll.202206948","volume":"19","author":"S Duan","year":"2023","unstructured":"Duan S, Wang S, Qiao L, Yu X, Wang N, Chen L, et al. Oncolytic Virus-Driven Biotherapies from Bench to Bedside. Small. 2023;19(23):e2206948.","journal-title":"Small"},{"issue":"1","key":"2823_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","volume":"8","author":"D Lin","year":"2023","unstructured":"Lin D, Shen Y, Liang T. Oncolytic virotherapy: basic principles, recent advances and future directions. Signal Transduct Target Therapy. 2023;8(1):156.","journal-title":"Signal Transduct Target Therapy"},{"issue":"24","key":"2823_CR37","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1128\/JVI.02116-13","volume":"87","author":"B Shai","year":"2013","unstructured":"Shai B, Schmukler E, Yaniv R, Ziv N, Horn G, Bumbarov V, et al. Epizootic hemorrhagic disease virus induces and exploits cellular stress, autophagy, and apoptosis. J Virol. 2013;87(24):13397\u2013408.","journal-title":"J Virol"},{"issue":"1","key":"2823_CR38","doi-asserted-by":"publisher","first-page":"24624","DOI":"10.1038\/s41598-025-08687-8","volume":"15","author":"S De","year":"2025","unstructured":"De S, Kashkash S, Bozhdansky V, Bacharach E, Ehrlich M. cJun-N-terminal kinase activity and mitosis perturbation drive the 2-methoxyestradiol-mediated enhancement of viral oncolysis by Epizootic Hemorrhagic Disease Virus-Tel Aviv University. Sci Rep. 2025;15(1):24624.","journal-title":"Sci Rep"},{"issue":"15","key":"2823_CR39","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1074\/jbc.273.15.8699","volume":"273","author":"P King","year":"1998","unstructured":"King P, Goodbourn S. STAT1 Is Inactivated by a Caspase*. J Biol Chem. 1998;273(15):8699\u2013704.","journal-title":"J Biol Chem"},{"issue":"7","key":"2823_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.cell.2014.11.037","volume":"159","author":"A Rongvaux","year":"2014","unstructured":"Rongvaux A, Jackson R, Harman Christian CD, Li T, West AP, de Zoete Marcel R, et al. Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA. Cell. 2014;159(7):1563\u201377.","journal-title":"Cell"},{"issue":"12","key":"2823_CR41","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/107999000750053762","volume":"20","author":"L Rusch","year":"2000","unstructured":"Rusch L, Zhou A, Silverman RH. Caspase-dependent apoptosis by 2\u2019,5\u2019-oligoadenylate activation of RNase L is enhanced by IFN-beta. J Interferon Cytokine Res. 2000;20(12):1091\u2013100.","journal-title":"J Interferon Cytokine Res"},{"issue":"38","key":"2823_CR42","doi-asserted-by":"publisher","first-page":"33037","DOI":"10.1074\/jbc.M111.257022","volume":"286","author":"N Sears","year":"2011","unstructured":"Sears N, Sen GC, Stark GR, Chattopadhyay S. Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation. J Biol Chem. 2011;286(38):33037\u201344.","journal-title":"J Biol Chem"},{"issue":"16","key":"2823_CR43","doi-asserted-by":"publisher","first-page":"15561","DOI":"10.1074\/jbc.M412630200","volume":"280","author":"Y Sun","year":"2005","unstructured":"Sun Y, Leaman DW. Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection. J Biol Chem. 2005;280(16):15561\u20138.","journal-title":"J Biol Chem"},{"issue":"8","key":"2823_CR44","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.onc.1205179","volume":"21","author":"L Thyrell","year":"2002","unstructured":"Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt O, Castro J, et al. Mechanisms of Interferon-alpha induced apoptosis in malignant cells. Oncogene. 2002;21(8):1251\u201362.","journal-title":"Oncogene"},{"issue":"7","key":"2823_CR45","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","volume":"159","author":"J White Michael","year":"2014","unstructured":"White Michael J, McArthur K, Metcalf D, Lane Rachael M, Cambier John C, Herold Marco J, et al. Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production. Cell. 2014;159(7):1549\u201362.","journal-title":"Cell"},{"key":"2823_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fimmu.2017.00313","volume":"8","author":"C Peteranderl","year":"2017","unstructured":"Peteranderl C, Herold S. The Impact of the Interferon\/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond. Front Immunol. 2017;8:313.","journal-title":"Front Immunol"},{"issue":"4","key":"2823_CR47","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/cdd.2009.156","volume":"17","author":"J Gao","year":"2010","unstructured":"Gao J, Senthil M, Ren B, Yan J, Xing Q, Yu J, et al. IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells. Cell Death Differ. 2010;17(4):699\u2013709.","journal-title":"Cell Death Differ"},{"issue":"3","key":"2823_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1023\/A:1023668705040","volume":"8","author":"M Chawla-Sarkar","year":"2003","unstructured":"Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis. 2003;8(3):237\u201349.","journal-title":"Apoptosis"},{"issue":"1","key":"2823_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/cdd.2013.75","volume":"21","author":"I Martins","year":"2014","unstructured":"Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ. 2014;21(1):79\u201391.","journal-title":"Cell Death Differ"},{"issue":"11","key":"2823_CR50","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, et al. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013.","journal-title":"Cell Death Dis"},{"key":"2823_CR51","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8(1):e000337.","DOI":"10.1136\/jitc-2019-000337corr1"},{"issue":"4","key":"2823_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487\u2013500.","journal-title":"Nat Immunol"},{"issue":"1","key":"2823_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54\u201361.","journal-title":"Nat Med"},{"issue":"5","key":"2823_CR54","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/emboj.2009.1","volume":"28","author":"T Panaretakis","year":"2009","unstructured":"Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 2009;28(5):578\u201390.","journal-title":"EMBO J"},{"issue":"7956","key":"2823_CR55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","volume":"616","author":"S Sen Santara","year":"2023","unstructured":"Sen Santara S, Lee DJ, Crespo \u00c2, Hu JJ, Walker C, Ma X, et al. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature. 2023;616(7956):348\u201356.","journal-title":"Nature"},{"issue":"2","key":"2823_CR56","doi-asserted-by":"publisher","first-page":"151328","DOI":"10.1016\/j.ejcb.2023.151328","volume":"102","author":"L Barer","year":"2023","unstructured":"Barer L, Schroder SK, Weiskirchen R, Bacharach E, Ehrlich M. Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection. Eur J Cell Biol. 2023;102(2):151328.","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"2823_CR57","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"269","key":"2823_CR58","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"key":"2823_CR59","doi-asserted-by":"publisher","first-page":"170151","DOI":"10.1038\/sdata.2017.151","volume":"4","author":"NF Fernandez","year":"2017","unstructured":"Fernandez NF, Gundersen GW, Rahman A, Grimes ML, Rikova K, Hornbeck P, et al. Clustergrammer, a web-based heatmap visualization and analysis tool for high-dimensional biological data. Sci Data. 2017;4:170151.","journal-title":"Sci Data"},{"key":"2823_CR60","unstructured":"Statistics Kingdom. Multiple Linear Regression Calculator. (October 30, 2023)[web application]. 2017. [Available from: https:\/\/www.statskingdom.com\/410multi_linear_regression.html."},{"key":"2823_CR61","doi-asserted-by":"crossref","unstructured":"Foty R. A simple hanging drop cell culture protocol for generation of 3D spheroids. J Vis Exp. 2011May 6:(51):2720.","DOI":"10.3791\/2720-v"},{"issue":"7","key":"2823_CR62","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1158\/1078-0432.CCR-24-2812","volume":"31","author":"L Colbert","year":"2025","unstructured":"Colbert L, Jia Y, Sharma A, Hu J, Xu Z, Suzman DL, et al. FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Gu\u00e9rin-Unresponsive Non-Muscle-Invasive Bladder Cancer. Clin cancer research: official J Am Association Cancer Res. 2025;31(7):1182\u20135.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"7757","key":"2823_CR63","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569(7757):503\u20138.","journal-title":"Nature"},{"issue":"7","key":"2823_CR64","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/carcin\/bgm070","volume":"28","author":"TA Zykova","year":"2007","unstructured":"Zykova TA, Zhu F, Zhang Y, Bode AM, Dong Z. Involvement of ERKs, RSK2 and PKR in UVA-induced signal transduction toward phosphorylation of eIF2alpha (Ser(51)). Carcinogenesis. 2007;28(7):1543\u201351.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2823_CR65","doi-asserted-by":"publisher","first-page":"e0360923","DOI":"10.1128\/spectrum.03609-23","volume":"12","author":"J Shu","year":"2024","unstructured":"Shu J, Ma X, Zou J, Yuan Z, Yi Z. Zika virus infection triggers caspase cleavage of STAT1. Microbiol Spectr. 2024;12(1):e0360923.","journal-title":"Microbiol Spectr"},{"issue":"51","key":"2823_CR66","doi-asserted-by":"publisher","first-page":"35102","DOI":"10.1074\/jbc.M114.597062","volume":"289","author":"SY Park","year":"2014","unstructured":"Park SY, Waheed AA, Zhang ZR, Freed EO, Bonifacino JS. HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor. J Biol Chem. 2014;289(51):35102\u201310.","journal-title":"J Biol Chem"},{"issue":"1","key":"2823_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molcel.2019.02.013","volume":"74","author":"X Ning","year":"2019","unstructured":"Ning X, Wang Y, Jing M, Sha M, Lv M, Gao P, et al. Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3. Mol Cell. 2019;74(1):19\u2013e317.","journal-title":"Mol Cell"},{"issue":"1","key":"2823_CR68","first-page":"151","volume":"56","author":"F Lin","year":"2020","unstructured":"Lin F, Yin HB, Li XY, Zhu GM, He WY, Gou X. Bladder cancer cell\u2013secreted exosomal miR\u201321 activates the PI3K\/AKT pathway in macrophages to promote cancer progression. Int J Oncol. 2020;56(1):151\u201364.","journal-title":"Int J Oncol"},{"issue":"7344","key":"2823_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481\u20135.","journal-title":"Nature"},{"issue":"6","key":"2823_CR70","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1(6):519\u201325.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"2823_CR71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1097-2765(00)80181-1","volume":"3","author":"BS Parekh","year":"1999","unstructured":"Parekh BS, Maniatis T. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. Mol Cell. 1999;3(1):125\u20139.","journal-title":"Mol Cell"},{"issue":"8","key":"2823_CR72","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.18632\/oncotarget.1911","volume":"5","author":"V Licht","year":"2014","unstructured":"Licht V, Noack K, Schlott B, F\u00f6rster M, Schlenker Y, Licht A, et al. Caspase-3 and caspase-6 cleave STAT1 in leukemic cells. Oncotarget. 2014;5(8):2305\u201317.","journal-title":"Oncotarget"},{"key":"2823_CR73","doi-asserted-by":"crossref","unstructured":"Quintas A, P\u00e9rez-N\u00fa\u00f1ez D, S\u00e1nchez EG, Nogal ML, Hentze MW, Castell\u00f3 A et al. Characterization of the African Swine Fever Virus Decapping Enzyme during Infection. J Virol. 2017;91(24):10-128.","DOI":"10.1128\/JVI.00990-17"},{"issue":"1","key":"2823_CR74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbrc.2008.07.147","volume":"375","author":"I Scott","year":"2008","unstructured":"Scott I, Norris KL. The mitochondrial antiviral signaling protein, MAVS, is cleaved during apoptosis. Biochem Biophys Res Commun. 2008;375(1):101\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2823_CR75","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41419-022-05156-2","volume":"13","author":"D Wu","year":"2022","unstructured":"Wu D, Wang Z, Zhang J, Robinson AG, Lyu B, Chen Z, et al. Apoptotic caspase inhibits innate immune signaling by cleaving NF-\u03baBs in both Mammals and Flies. Cell Death Dis. 2022;13(8):731.","journal-title":"Cell Death Dis"},{"key":"2823_CR76","doi-asserted-by":"crossref","unstructured":"Wu S-Q, Xu R, Li X-F, Zhao X-K, Qian B-Z. Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis. Oncotarget. 2018;9(38):25294.","DOI":"10.18632\/oncotarget.25334"},{"issue":"4","key":"2823_CR77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.urolonc.2013.10.012","volume":"32","author":"L Lima","year":"2014","unstructured":"Lima L, Oliveira D, Tavares A, Amaro T, Cruz R, Oliveira MJ, et al. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Urol Oncol. 2014;32(4):449\u201357.","journal-title":"Urol Oncol"},{"issue":"3","key":"2823_CR78","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2020009081","volume":"138","author":"JB Lee","year":"2021","unstructured":"Lee JB, Khan DH, Hurren R, Xu M, Na Y, Kang H, et al. Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood. 2021;138(3):234\u201345.","journal-title":"Blood"},{"issue":"9","key":"2823_CR79","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","volume":"185","author":"R Pan","year":"2022","unstructured":"Pan R, Ryan J, Pan D, Wucherpfennig KW, Letai A. Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. Cell. 2022;185(9):1521\u2013e3818.","journal-title":"Cell"},{"issue":"2","key":"2823_CR80","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/art.27198","volume":"62","author":"JC Scatizzi","year":"2010","unstructured":"Scatizzi JC, Hutcheson J, Pope RM, Firestein GS, Koch AE, Mavers M, et al. Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum. 2010;62(2):441\u201351.","journal-title":"Arthritis Rheum"},{"issue":"16","key":"2823_CR81","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JVI.02672-08","volume":"83","author":"JE McLean","year":"2009","unstructured":"McLean JE, Datan E, Matassov D, Zakeri ZF. Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. J Virol. 2009;83(16):8233\u201346.","journal-title":"J Virol"},{"key":"2823_CR82","doi-asserted-by":"crossref","unstructured":"Bishnoi S, Tiwari R, Gupta S, Byrareddy SN, Nayak D. Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy. Viruses. 2018;10(2):90.","DOI":"10.3390\/v10020090"},{"key":"2823_CR83","doi-asserted-by":"crossref","unstructured":"Fink SL, Jayewickreme TR, Molony RD, Iwawaki T, Landis CS, Lindenbach BD et al. IRE1\u03b1 promotes viral infection by conferring resistance to apoptosis. Sci Signal. 2017;10(482):eaai7814.","DOI":"10.1126\/scisignal.aai7814"},{"issue":"1","key":"2823_CR84","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1158\/2159-8290.CD-NB2015-158","volume":"6","author":"A Poh","year":"2016","unstructured":"Poh A. First Oncolytic Viral Therapy for Melanoma. Cancer Discov. 2016;6(1):6.","journal-title":"Cancer Discov"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02823-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:02:05Z","timestamp":1777629725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02823-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2823"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02823-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}